Despite a decline in some of Pfizer’s drugs, the company reported strong sales growth for the quarter. Although growth in the covid-19 vaccine market is expected to accelerate before yearend, Pfizer indicated that sales from its coronavirus vaccine may decline in the current quarter.
Wednesday, 03 Nov, 2021 / 9:55
